What is the common examiner trap about Polity in UPSC exams?

Confusing the 'Drug Consultative Committee' (advisory) with the 'Drug Technical Advisory Board' (technical) or the 'Drug Controller General of India' (executive). Also, note that the recommendation is for 'states' to act, not CDSCO directly.

What should UPSC aspirants remember about Polity for Prelims?

1. Target this Data: Meeting date June 24, 2026; deadline for state reporting: before 10th of every month 2. Target this Nodal Body: Central Drugs Standard Control Organisation (CDSCO) under Ministry of Health and Family Welfare 3. Target this Legal Point: Drugs and Cosmetics Act, 1940; Drugs Rules (for potential amendment on packaging materials)

GovernanceSocial_Issues

Take AI Challenge ▸

News 0 of 27

Drug Consultative Committee Directs States to Publish Licence Suspension, Recall Orders Online; Share with CDSCO

Q: Which organisation is the apex drug regulator in India, under which the Drug Consultative Committee operates?

Central Drugs Standard Control Organisation (CDSCO), CDSCO is the national regulatory authority for drugs and cosmetics. The Drug Consultative Committee is an expert committee under the apex drug regulator, which is CDSCO (or DCGI as its head). The Ministry of Health is the parent ministry, not the regulator itself. DCGI is the head of CDSCO, but the organisation is CDSCO.

Q: Consider the following statements regarding the recent recommendations of the Drug Consultative Committee: 1. State drug authorities must post orders related to suspension or cancellation of licences on their official websites. 2. The committee recommended that states share details of regulatory actions with CDSCO before the 15th of every month. 3. A sub-committee has been constituted to examine the registration of suppliers of printed material used for drug packaging. Which of the statements given above is/are correct?

Both 1 and 3, Statement 1 is correct: the committee recommended that states put up all orders (suspension, cancellation, stop production, recall) online. Statement 2 is incorrect: the deadline is 'before the 10th of every month', not 15th. Statement 3 is correct: a sub-committee was recommended to study the necessity and feasibility of registering packaging material suppliers.

Q: By what date of each month must state drug authorities share details of regulatory actions with the Central Drugs Standard Control Organisation (CDSCO) as per the committee's recommendation?

10th, The article explicitly states that the committee recommended sharing details 'before the 10th of every month'. The 5th, 15th, and end of month are distractors.

Q: What is the primary objective of the Drug Consultative Committee's recommendation to publish regulatory actions online?

To ensure transparency and prevent regulatory disconnect between states, The article highlights that details of regulatory actions are not uploaded by states, leading to a 'regulatory disconnect' where manufacturers with cancelled licences submit photocopies. The recommendation aims to make the information public and share it with CDSCO to prevent such exploitation. Option A is not the primary objective; option C is not mentioned; option D is incorrect because CDSCO cannot act independently—state regulators are responsible for enforcement.

Polity Social IssuesHIGH

Target:UPSC GS-IIMPSCSSC GATeachingPrelims HighMains MediumStatic GK Link

08 Jul 2026

~2 min

Source: Indian Express

Key Data:June 24, 2026before the 10th of every monthsub-committee on packaging materials

Bodies:CDSCODrug Consultative Committee

Practice MCQs from today's news ▸

~2 min · Quick mode

What This Article Covers

1.Expert committee under the apex drug regulator recommends states to put regulatory orders online and share with CDSCO before 10th of every month.

2.Move aims to eliminate regulatory disconnect where manufacturers with cancelled licences submit photocopies for procurement orders.

3.Sub-committee proposed to study registration of packaging material suppliers to prevent counterfeit drug introduction.

The Big Picture

Prelims · HighMains · Medium

The Drug Consultative Committee has recommended that state drug authorities publish all regulatory actions (licence suspension, recall orders) online and share monthly lists with CDSCO. This aims to curb regulatory disconnect and prevent circulation of substandard/fake drugs. Exam angle: Prelims focus on CDSCO, NSQ drugs, and regulatory reforms; Mains linkage to governance, transparency, and public health.

Exam Lens

Quick Exam Facts From News

Meeting DateJune 24, 2026

Reporting DeadlineBefore 10th of every month

Sub-committee FocusRegistration of packaging material suppliers

1-Minute Revision

›Meeting Date: June 24, 2026
›Reporting Deadline: Before 10th of every month
›Target this Data: Meeting date June 24, 2026; deadline for state reporting: before 10th of every month
›Target this Nodal Body: Central Drugs Standard Control Organisation (CDSCO) under Ministry of Health and Family Welfare
›Target this Legal Point: Drugs and Cosmetics Act, 1940; Drugs Rules (for potential amendment on packaging materials)

Mastered this topic? Test your knowledge with a full MCQ quiz.

Practice exam-style questions, track your score, and strengthen your recall.

News Snapshot

🏛️

Drug Consultative Committee

Expert committee under the apex drug regulator recommends states to post licence suspension/recall orders online.

📢

Transparency in Regulatory Actions

Aims to ensure public awareness and prevent regulatory disconnect across states via monthly reporting to CDSCO.

🔄

Counterfeit Drug Prevention

Sub-committee proposed to register packaging material suppliers to curb diversion and misuse of printed materials.

Detailed Analysis & Strategic Depth

Context / Background

The Drug Consultative Committee observed that several states fail to upload regulatory actions on their websites, leading to a regulatory disconnect. Manufacturers with cancelled licences exploit this gap by submitting photocopies of old licences for procurement orders, undermining drug quality control.

Core Analysis & Implications

The three recommendations address transparency, accountability, and data sharing. Publishing orders online serves as a 'naming and shaming' mechanism, though implementation depends on state compliance. Monthly sharing of NSQ drug lists with CDSCO is already required but remains incomplete, highlighting enforcement challenges. The sub-committee on packaging materials targets a key weak point in counterfeit drug supply chains.

Future Outlook / Way Forward

States must now operationalise the recommendations. The sub-committee will report on necessity and feasibility of registering packaging material suppliers, potentially amending the Drugs Rules. If implemented, these measures could significantly reduce regulatory gaps and improve drug safety, but uniform state compliance remains a hurdle.

Key Facts at a Glance

Meeting DateJune 24, 2026

Reporting DeadlineBefore 10th of every month

Sub-committee FocusRegistration of packaging material suppliers

You've read the full analysis. Now test your understanding.

Practice exam-style questions based on this article.

Q1Static LinkageEasyUPSC, SSC, Banking, State PSC

Which organisation is the apex drug regulator in India, under which the Drug Consultative Committee operates?

Q2Statement-basedHardUPSC, SSC, Banking

Consider the following statements regarding the recent recommendations of the Drug Consultative Committee:

1. State drug authorities must post orders related to suspension or cancellation of licences on their official websites.

2. The committee recommended that states share details of regulatory actions with CDSCO before the 15th of every month.

3. A sub-committee has been constituted to examine the registration of suppliers of printed material used for drug packaging.

Which of the statements given above is/are correct?

Q3Data-centricMediumUPSC, SSC, Banking

By what date of each month must state drug authorities share details of regulatory actions with the Central Drugs Standard Control Organisation (CDSCO) as per the committee's recommendation?

Q4Application/ImpactMediumUPSC, SSC, Banking

What is the primary objective of the Drug Consultative Committee's recommendation to publish regulatory actions online?

All 25 MCQs ▸

Read original article from Indian Express

You finished this topic

Practice 3 MCQs from this news Next Article

Explore Related Topics

PolityView Topic MCQs →Social IssuesView Topic MCQs →

Next India-EU FTA to Enter Force by Q1 2027: 99% of Indian Exports Tariff-Free, €500M EU Green Aid

Related Current Affairs

Polity Current Affairs

MahaRERA Strikes Down Builder's Unilateral Cancellation Clause, Orders Interest from Oct 2023 Under RERA Act

MahaRERA has declared illegal a contractual clause that allowed a builder to unilaterally cancel a flat allotment via Power of Attorney, reinforcing statutory safeguards under the RERA Act. The developer was ordered to pay interest for delayed possession from October 1, 2023. This ruling is a key example of regulatory protection for homebuyers and a must-know for exams covering RERA, consumer rights, and state-level governance.

Polity Current Affairs

MoTA Directs States for Jan Sunwai Camps at Adi Sewa Kendras Ahead of Independence Day

The Ministry of Tribal Affairs has directed all states to hold 'Jan Sunwai' camps at Adi Sewa Kendras from August 13-15 for doorstep delivery of tribal welfare schemes. This initiative is part of the Adi Karmayogi Abhiyan, launched in September 2025, aiming to build grassroots tribal leadership. This is a crucial governance push for tribal welfare, linking directly to schemes like PM-JANMAN and DAJGUA.

Polity Current Affairs

SC Directs Centre on NTA Reform: Radhakrishnan & Nilekani Committee Recommendations

The Supreme Court has directed the Centre to file an affidavit on implementing recommendations of the K Radhakrishnan and Nandan Nilekani committees to reform the NTA, aiming to make it a vibrant, foolproof institution like the UPSC. The court stressed institutionalisation with proper infrastructure, manpower, and technology to prevent exam leaks and ensure integrity.

Health & Education Current Affairs

Union Health Ministry Mandates CCTV at Medical Stores for Schedule H, H1, X Drug Sales; 3-Month Recordings

The Union Health Ministry has proposed mandatory CCTV installation at medical stores selling prescription and habit-forming drugs (Schedule H, H1, X) to curb unauthorized sale and drug abuse, especially among children. Chemists oppose citing cost, privacy, and rural connectivity issues. The move involves CDSCO and the Drugs Consultative Committee.

Polity Current Affairs

FSDA Cancels 16 Pharma Licences, Suspends Pfizer Depot in Bengaluru Fake Drug Bust Worth ₹5 Cr

Karnataka FSDA has cancelled 16 pharma licences and suspended 8 others, including Pfizer's depot, after seizing counterfeit drugs worth ₹5 crore from farmhouses. The racket involved refilling cheap drugs into vials of expensive MNC brands, posing a serious public health risk. This highlights gaps in drug regulatory enforcement and the need for stricter supply chain vigilance.

Polity Current Affairs

J&K House Committee Flags ₹1100 Cr Irregularities in Jal Jeevan Mission, Seeks Probe

The J&K House Committee report exposes gross negligence and widespread irregularities in ₹1100 crore Jal Jeevan Mission projects, including poor civil works, unauthorized pipe substitution, and false claims of tap connections. This raises serious questions about the flagship scheme's implementation and accountability, making it a critical governance issue for exams.

Polity Current Affairs

Calcutta HC Orders 5 Fast-Track Courts for NEET Paper Leak Cases Under 2024 Act

The Calcutta High Court has ordered five dedicated fast-track courts—three in Kolkata and two in Port Blair—to exclusively try NEET paper leak cases under the Public Examinations (Prevention of Unfair Means) Act, 2024, with a strict deadline to conclude trial within three months from filing of charge-sheet. This move aims to expedite justice in one of India's biggest education scandals and follows nationwide protests and the resignation of the Union Education Minister.

Social Issues Current Affairs

FSSAI Issues Prohibition Order to Dabur for Misleading '100%' Claims on Food Products

FSSAI's crackdown on misleading '100%' claims on food products is a major regulatory action that tests your understanding of the FSS Act, 2006, and the FSS (Advertising & Claims) Regulations, 2018. This news is relevant for Prelims (FSSAI, regulations, consumer protection) and Mains (food safety, ethics in business, regulatory framework).

Start Today's Quiz(25 Qs)

Take Today's Quiz

25 Qs • 5-7 Mins

Drug Consultative Committee Directs States to Publish Licence Suspension, Recall Orders Online; Share with CDSCO

Exam Lens

Quick Exam Facts From News

1-Minute Revision

News Snapshot

Drug Consultative Committee

Transparency in Regulatory Actions

Counterfeit Drug Prevention

Detailed Analysis & Strategic Depth

Context / Background

Core Analysis & Implications

Future Outlook / Way Forward

Prelims Flashpoints

Key Facts at a Glance